Roche Holding AG
http://www.roche.com
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Roche Holding AG
Investor Faith In David Hung’s Nuvation Renewed By Anheart Buyout
The acquisition brings two potential best-in-class cancer therapies, which could make Nuvation a commercial company as soon as 2025.
Proposed US BIOSECURE Act - Do Lonza, Other CDMOs Gain And How Soon?
Concerns over the impact of the proposed US BIOSECURE Act on the CRO and CDMO segments linger despite proponent Mike Gallagher’s plan to leave Congress soon. Which global manufacturers could gain, what determines a shift away from Chinese companies and how imminent is this? Scrip brings insights from industry feedback and other sources.
Sellas Teases Biomarker-Driven Efficacy Of AML Drug With Phase IIa Results
The company remained tight-lipped on the biomarker driving high response rates for its CDK9 inhibitor SLS009 from a Phase II trial, as a Phase III interim analysis for its AML cancer vaccine galinpepimut-S draws near.
Outlook Turns To Marketing Strategy After Scoring EU First For Ophthalmic Bevacizumab
Outlook Therapeutics’ intravitreally injected Lytenava has won the thumbs up from the European Medicines Agency. The company is assessing both direct commercialization of the product and partnering in Europe on a country-by-country basis.
Company Information
- Industry
- In Vitro Diagnostics
- Pharmaceuticals
-
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
- Other Names / Subsidiaries
-
- Adheron Therapeutics
- Anadys Pharmaceuticals, Inc.
- Ariosa Diagnostics
- Arius Research, Inc.
- Boehringer Mannheim
- CAPP Medical
- Chugai Pharmaceutical Co., Ltd.
- Dutalys GmbH
- Flatiron Health
- Foundation Medicine
- GenMark Diagnostics, Inc.
- Genentech Inc.
- GeneWEAVE BioSciences, Inc.
- Genia Technologies, Inc.
- GlycArt Biotechnology
- Hoffmann-La Roche
- Inflazome Ltd.
- Ignyta, Inc. (RXDX) (Actagene Oncology, Inc
- NexDx, Inc.)
- Inception 5
- InterMune, Inc.
- Inflazome Ltd.
- IQuum, Inc.
- Jecure Therapeutics
- Kapa Biosystems, Inc.
- Marcadia Biotech, Inc.
- Medingo Ltd.
- Memory Pharmaceuticals Corporation
- mtm laboratories AG
- Piramed Pharma
- Santaris Pharma A/S
- Seragon Pharmaceuticals
- Signature Diagnostics AG
- Stratos Genomics
- Syntex Corporation
- Tanox, Inc.
- Tensha Therapeutics, Trophos SA
- Ventana Medical Systems, Inc.
- Viewics, Inc.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice